DELIARGYRIS EFTHYMIOS (Chief Medical Officer) reported 1 transaction at CYTOSORBENTS CORP
Review the transaction codes below to understand the nature of each event.
Filed: 1/22/2025ACC: 0001104659-25-005355
Officer· Chief Medical Officer
Since May 2020
+32.47K
Net shares
Net buyer
$16.2K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
48.70K acquired · 16.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.23K
Price / share
$1.00
Trade value
$16.23K
% of position
4.2%
1/17/2025
386.79K→403.02K
Total
Net shares
+16.23K
Net value
$16.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2025 | X · X | +16.23K | $1.00 | $16.23K | 4.2% | 386.79K | 403.02K |
| Total | +16.23K | $16.23K | ||||||
Derivative Transactions3
Subscription Rights (right to buy)
Direct
Converts to
Common Stock
16.23K shares
Shares
−16.23K
Strike price
1.00
Held after
0.00
Exercisable
—
1/17/2025
Series A Right Warrants
Direct
Converts to
Common Stock
16.23K shares
Shares
+16.23K
Strike price
Held after
16.23K
Exercisable
—
1/17/2025
Series B Right Warrants
Direct
Converts to
Common Stock
16.23K shares
Shares
+16.23K
Strike price
Held after
16.23K
Exercisable
—
1/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Subscription Rights (right to buy) Direct | Common Stock16.23K shares | 1/17/2025 | X · X | −16.23K | 1.00 | — | 0.00 |
| Series A Right Warrants Direct | Common Stock16.23K shares | 1/17/2025 | J · J | +16.23K | — | 16.23K | |
| Series B Right Warrants Direct | Common Stock16.23K shares | 1/17/2025 | J · J | +16.23K | — | 16.23K |